Preventive and unlimited Corrective Repair (Essentialcare or equal) service agreement for a Surface Plasmon Resonance (SPR) Biacore T200 instrument, Base plus two (2) option years

Key Dates
Due Date

-

Posted Date

-

Agency & Value
Agency

FDA OFFICE OF ACQ GRANT SVCS

Contract Value

Not provided

Codes & Classification
Solicitation Number

75F40126Q135706

NAICS

811210 - Electronic and Precision Equipment Repair and Maintenance

Classification Code

J066

Additional Details
Set Aside

NONE

Place of Performance

-

SourceSAM
Documents2
The Food and Drug Administration (FDA), operating under the Department of Health and Human Services, has issued a combined synopsis/solicitation for a service agreement covering preventive maintenance and corrective repair for a Surface Plasmon Resonance (SPR) Biacore T200 instrument. This procurement, identified by solicitation number 75F40126Q135706, seeks to establish a base contract with two additional option years, ensuring ongoing support and operational reliability for this critical scientific equipment. The scope of the agreement encompasses comprehensive preventive maintenance services, as well as corrective repairs, for the Biacore T200 instrument. The requirement specifies an "Essentialcare or equal" service standard, indicating that the level of service must meet or exceed the manufacturer's recommended protocols for maintaining and repairing the SPR system. The intended outcome is to maximize instrument uptime, maintain performance integrity, and support the FDA’s research and analytical capabilities. Recent amendments to the solicitation clarify several key points. Notably, the requirement for "Unlimited Corrective Repairs" has been removed, focusing the agreement on preventive maintenance and necessary corrective actions as defined in the revised solicitation. The procurement is conducted on a full and open, unrestricted basis, meaning businesses of any size are eligible to submit quotations. There are no set-aside provisions for small businesses, and the previously included FAR clause 52.219-6 has been eliminated to reflect this unrestricted competition. Offerors must also address Information and Communication Technology (ICT) accessibility requirements. The Accessibility Conformance Report (ACR) must comply with HHSAR provision 352.239-78 and clause 352.239-79, as specified in the solicitation. These standards ensure that any ICT-related deliverables meet federal accessibility guidelines. The procurement is classified under NAICS code 811210 (Electronic and Precision Equipment Repair and Maintenance), with product service code J066, indicating a focus on maintenance and repair services for scientific and medical equipment. The contracting entity is the FDA Office of Acquisition and Grant Services, a federal office responsible for managing procurement activities for the agency. Interested contractors should note the following details: - Solicitation Number: 75F40126Q135706 - Contracting Entity: FDA Office of Acquisition and Grant Services - Department: Health and Human Services, Food and Drug Administration - NAICS Code: 811210 (2022 version) - Product Service Code: J066 - Competition Type: Full and open, unrestricted - Set-Aside: None - Primary Contact: Suzanne Martella ([email protected], 301-796-2383) - Response Deadline: August 10, 2026, at 2:00pm Central Time - Notice URL: https://sam.gov/opp/8003130fb1cc4d13b3ca577bb37a1098/view Contractors evaluating this opportunity should ensure their service offerings align with the preventive maintenance and corrective repair requirements for the Biacore T200 instrument, and that their ICT deliverables meet the specified accessibility standards. The contract is intended to provide reliable, expert support for a sophisticated scientific instrument over a multi-year period, supporting the FDA’s mission-critical operations. All quotations must reference the correct solicitation number and adhere to the updated requirements as outlined in the solicitation and subsequent amendments.